FONR Quote, Financials, Valuation and Earnings

Interpace Biosciences, Inc. has a net margin of 9.94% compared to FONAR Corp.'s net margin of 11.55%. FONAR Corp.'s return on equity of 6.02% beat Interpace Biosciences, Inc.'s return on equity of --.

FONAR Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Interpace Biosciences, Inc. has an analysts' consensus of -- which suggests that it could grow by 494.6%. Given that Interpace Biosciences, Inc. has higher upside potential than FONAR Corp., analysts believe Interpace Biosciences, Inc. is more attractive than FONAR Corp..

FONAR Corp. has a beta of 1.002, which suggesting that the stock is 0.18499999999999% more volatile than S&P 500. In comparison Interpace Biosciences, Inc. has a beta of 1.115, suggesting its more volatile than the S&P 500 by 11.457%.

FONAR Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Interpace Biosciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. FONAR Corp. pays -- of its earnings as a dividend. Interpace Biosciences, Inc. pays out -- of its earnings as a dividend.

FONAR Corp. quarterly revenues are $25.5M, which are larger than Interpace Biosciences, Inc. quarterly revenues of $8.8M. FONAR Corp.'s net income of $2.5M is higher than Interpace Biosciences, Inc.'s net income of $1M. Notably, FONAR Corp.'s price-to-earnings ratio is 16.52x while Interpace Biosciences, Inc.'s PE ratio is 6.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for FONAR Corp. is 1.12x versus 0.71x for Interpace Biosciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Thermo Fisher Scientific, Inc. has a net margin of 9.94% compared to FONAR Corp.'s net margin of 16.21%. FONAR Corp.'s return on equity of 6.02% beat Thermo Fisher Scientific, Inc.'s return on equity of 13.23%.

FONAR Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Thermo Fisher Scientific, Inc. has an analysts' consensus of $666.46 which suggests that it could grow by 30.44%. Given that Thermo Fisher Scientific, Inc. has higher upside potential than FONAR Corp., analysts believe Thermo Fisher Scientific, Inc. is more attractive than FONAR Corp..

FONAR Corp. has a beta of 1.002, which suggesting that the stock is 0.18499999999999% more volatile than S&P 500. In comparison Thermo Fisher Scientific, Inc. has a beta of 0.928, suggesting its less volatile than the S&P 500 by 7.166%.

FONAR Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Thermo Fisher Scientific, Inc. offers a yield of 0.34% to investors and pays a quarterly dividend of $0.43 per share. FONAR Corp. pays -- of its earnings as a dividend. Thermo Fisher Scientific, Inc. pays out 9.7% of its earnings as a dividend. Thermo Fisher Scientific, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

FONAR Corp. quarterly revenues are $25.5M, which are smaller than Thermo Fisher Scientific, Inc. quarterly revenues of $12.2B. FONAR Corp.'s net income of $2.5M is lower than Thermo Fisher Scientific, Inc.'s net income of $2B. Notably, FONAR Corp.'s price-to-earnings ratio is 16.52x while Thermo Fisher Scientific, Inc.'s PE ratio is 28.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for FONAR Corp. is 1.12x versus 4.33x for Thermo Fisher Scientific, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Veracyte, Inc. has a net margin of 9.94% compared to FONAR Corp.'s net margin of 14.51%. FONAR Corp.'s return on equity of 6.02% beat Veracyte, Inc.'s return on equity of 2.52%.

FONAR Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Veracyte, Inc. has an analysts' consensus of $47.67 which suggests that it could grow by 33.78%. Given that Veracyte, Inc. has higher upside potential than FONAR Corp., analysts believe Veracyte, Inc. is more attractive than FONAR Corp..

FONAR Corp. has a beta of 1.002, which suggesting that the stock is 0.18499999999999% more volatile than S&P 500. In comparison Veracyte, Inc. has a beta of 1.913, suggesting its more volatile than the S&P 500 by 91.288%.

FONAR Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veracyte, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. FONAR Corp. pays -- of its earnings as a dividend. Veracyte, Inc. pays out -- of its earnings as a dividend.

FONAR Corp. quarterly revenues are $25.5M, which are smaller than Veracyte, Inc. quarterly revenues of $131.9M. FONAR Corp.'s net income of $2.5M is lower than Veracyte, Inc.'s net income of $19.1M. Notably, FONAR Corp.'s price-to-earnings ratio is 16.52x while Veracyte, Inc.'s PE ratio is 93.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for FONAR Corp. is 1.12x versus 5.72x for Veracyte, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

XWELL, Inc. has a net margin of 9.94% compared to FONAR Corp.'s net margin of -2.87%. FONAR Corp.'s return on equity of 6.02% beat XWELL, Inc.'s return on equity of -224.93%.

FONAR Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand XWELL, Inc. has an analysts' consensus of -- which suggests that it could grow by 1743.08%. Given that XWELL, Inc. has higher upside potential than FONAR Corp., analysts believe XWELL, Inc. is more attractive than FONAR Corp..

FONAR Corp. has a beta of 1.002, which suggesting that the stock is 0.18499999999999% more volatile than S&P 500. In comparison XWELL, Inc. has a beta of 1.511, suggesting its more volatile than the S&P 500 by 51.09%.

FONAR Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. XWELL, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. FONAR Corp. pays -- of its earnings as a dividend. XWELL, Inc. pays out -- of its earnings as a dividend.

FONAR Corp. quarterly revenues are $25.5M, which are larger than XWELL, Inc. quarterly revenues of $7.3M. FONAR Corp.'s net income of $2.5M is higher than XWELL, Inc.'s net income of -$211K. Notably, FONAR Corp.'s price-to-earnings ratio is 16.52x while XWELL, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for FONAR Corp. is 1.12x versus 0.07x for XWELL, Inc.. Usually stocks with elevated PS ratios are considered overvalued.